Search results for "Hepatitis C virus"
Nearly all patients in study achieved sustained virologic response after 12 weeks of new HCV treatment
The drug combination appeared effective in adults with HCV genotypes 1, 2, 4, 5, or 6 infection and compensated cirrhosis in the industry-funded trial.
https://gastroenterology.acponline.org/archives/2017/08/25/3.htm
25 Aug 2017
Prophylactic HCV treatment with direct-acting antivirals appears safe in noninfected kidney recipients
Researchers studied 10 HCV-negative recipients of 10 HCV-positive donor kidneys in an open-label, nonrandomized trial.
https://gastroenterology.acponline.org/archives/2018/03/23/3.htm
23 Mar 2018
HCV treatment by NPs, PCPs appears safe, effective as that provided by subspecialists
Reversing insurance restrictions that limit prescribing of direct-acting antivirals might allow rapid escalation of safe, effective therapy for hepatitis C virus (HCV) infection and could improve the care of patients, study authors noted.
https://gastroenterology.acponline.org/archives/2017/08/25/6.htm
25 Aug 2017
ACP, CDC issue best practice advice on HBV
Clinicians should screen for hepatitis B virus (HBV) in patients at high risk, such as those born in countries where the HBV prevalence is 2% or higher, men who have sex with men, patients who require immunosuppressive therapy, or patients with end-stage renal disease.
https://gastroenterology.acponline.org/archives/2017/11/28/7.htm
28 Nov 2017
Spotlight on hepatitis B vaccination
The Advisory Committee on Immunization Practices released new recommendations, a CDC-funded study examined vaccination rates among patients who have HIV infection, and the FDA approved a new vaccine.
https://gastroenterology.acponline.org/archives/2018/01/26/5.htm
26 Jan 2018
New HCV drug combo approved
The fixed-dose tablet combines the previously approved drugs sofosbuvir and velpatasvir with a new drug, voxilaprevir.
https://gastroenterology.acponline.org/archives/2017/07/28/10.htm
28 Jul 2017
Study finds substantial increase in HCV infection among younger women, children
Data from the National Notifiable Diseases Surveillance System and the Quest Diagnostics Health Trends database were used to estimate the incidence of hepatitis C virus (HCV) infection among women ages 15 to 44 years and children ages 2 to 13 years.
https://gastroenterology.acponline.org/archives/2017/05/26/1.htm
26 May 2017
8 weeks of ledipasvir/sofosbuvir may be effective for genotype 1 hepatitis C
The therapy should be considered in patients with genotype 1 infection who are treatment-naive, do not have cirrhosis, and have a pretreatment viral load below 6,000,000 IU/mL, a study found.
https://gastroenterology.acponline.org/archives/2017/03/24/2.htm
24 Mar 2017
ACG guidelines advise on diagnosis, treatment of alcoholic liver disease
Patients with heavy alcohol use should be counseled that they are at increased risk for alcoholic liver disease, among other recommendations from the American College of Gastroenterology.
https://gastroenterology.acponline.org/archives/2018/01/26/1.htm
26 Jan 2018